ES2575731B1 - Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves - Google Patents
Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves Download PDFInfo
- Publication number
- ES2575731B1 ES2575731B1 ES201531877A ES201531877A ES2575731B1 ES 2575731 B1 ES2575731 B1 ES 2575731B1 ES 201531877 A ES201531877 A ES 201531877A ES 201531877 A ES201531877 A ES 201531877A ES 2575731 B1 ES2575731 B1 ES 2575731B1
- Authority
- ES
- Spain
- Prior art keywords
- synthetic model
- model according
- synthetic
- acetonitrile
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000011156 evaluation Methods 0.000 title abstract description 5
- 230000005540 biological transmission Effects 0.000 title abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 79
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 39
- 239000011780 sodium chloride Substances 0.000 claims abstract description 20
- 229920000642 polymer Polymers 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000499 gel Substances 0.000 claims description 13
- 238000006116 polymerization reaction Methods 0.000 claims description 10
- 239000003139 biocide Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical group [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 6
- 239000002798 polar solvent Substances 0.000 claims description 6
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 6
- 230000008961 swelling Effects 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000004088 simulation Methods 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229940045110 chitosan Drugs 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- FEWFXBUNENSNBQ-UHFFFAOYSA-N 2-hydroxyacrylic acid Chemical class OC(=C)C(O)=O FEWFXBUNENSNBQ-UHFFFAOYSA-N 0.000 claims 1
- 241000206672 Gelidium Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 210000000056 organ Anatomy 0.000 abstract description 11
- 238000012360 testing method Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 2
- 239000011159 matrix material Substances 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 22
- 239000000243 solution Substances 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 229920002401 polyacrylamide Polymers 0.000 description 6
- 210000001072 colon Anatomy 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 240000002426 Persea americana var. drymifolia Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 230000005288 electromagnetic effect Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- AZIQALWHRUQPHV-UHFFFAOYSA-N prop-2-eneperoxoic acid Chemical compound OOC(=O)C=C AZIQALWHRUQPHV-UHFFFAOYSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R29/00—Arrangements for measuring or indicating electric quantities not covered by groups G01R19/00 - G01R27/00
- G01R29/08—Measuring electromagnetic field characteristics
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
Landscapes
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Educational Technology (AREA)
- Chemical & Material Sciences (AREA)
- Algebra (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Pure & Applied Mathematics (AREA)
- Business, Economics & Management (AREA)
- Educational Administration (AREA)
- Medicinal Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Electromagnetism (AREA)
- Computational Mathematics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Instructional Devices (AREA)
Abstract
Modelo sintético de tejidos biológicos para la evaluación de la transmisión inalámbrica de ondas electromagnéticas.#La presente invención se refiere a modelos sintéticos o phantoms de tejido y órganos biológicos compuesto principalmente por cloruro sódico y acetonitrilo en disolución o embebidos en una matriz polimérica y a su uso para testar los posibles efectos de las ondas electromagnéticas en los seres vivos, particularmente en el rango de frecuencias de 0,5 a 18 GHz.Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves. # The present invention relates to synthetic models or phantoms of tissue and biological organs composed mainly of sodium chloride and acetonitrile in solution or embedded in a polymer matrix and for use to test the possible effects of electromagnetic waves on living beings, particularly in the frequency range of 0.5 to 18 GHz.
Description
55
1010
15fifteen
20twenty
2525
3030
Modelo sintetico de tejidos bioloqicos para la evaluacion de la transmision inalambrica de ondas electromagneticasSynthetic model of biological tissues for the evaluation of the wireless transmission of electromagnetic waves
DESCRIPCIONDESCRIPTION
La presente invention se refiere a modelos sinteticos de tejido y organos biologicos compuesto principalmente por cloruro sodico y acetonitrilo en disolucion o embebidos en una matriz polimerica y a su uso para testar los posibles efectos de las ondas electromagneticas en los seres vivos, particularmente en el rango de frecuencias de 0,5 a 18 GHz.The present invention relates to synthetic models of tissue and biological organs composed mainly of sodium chloride and acetonitrile in solution or embedded in a polymer matrix and its use to test the possible effects of electromagnetic waves in living beings, particularly in the range of frequencies from 0.5 to 18 GHz.
ESTADO DE LA TECNICASTATE OF THE TECHNIQUE
Existe un interes creciente en emplear dispositivos de telecomunicaciones, bien sea como capsulas de administration oral o como sensores o sistemas de monitorizacion medicos implantables, de corta o larga vida, para registrar information biologica del interior del organismo y poderla transmitir al exterior, con el fin de realizar un diagnostico cllnico o ajustar el tratamiento medico ante una patologla cronica con mayor precision. Para ello, dichos dispositivos se comunican inalambricamente enviando ondas electromagneticas a traves del cuerpo, que se comporta como medio de transmision. Para poder desarrollar y testear dispositivos de este tipo antes de su comercializacion, se hace necesaria, llegado cierto punto, la experimentation animal y en humanos.There is a growing interest in using telecommunications devices, either as oral administration capsules or as implantable medical sensors or monitoring systems, of short or long life, to record biological information from inside the organism and be able to transmit it to the outside, in order to make a clinical diagnosis or adjust the medical treatment before a chronic pathology with greater precision. For this, said devices communicate wirelessly by sending electromagnetic waves through the body, which behaves as a means of transmission. In order to develop and test devices of this type before marketing, it becomes necessary, at a certain point, animal and human experimentation.
Para evitar recurrir a la experimentacion animal o humana (lo que se suele denominar ensayos in vivo), se ha desarrollado un modelo sintetico (llamado phantom o fantoma en castellano) que se basan en mezclas de distintos componentes cuyas concentraciones se ajustan para simular distintos tejidos humanos y organos, y que evita en parte tener que recurrir a los de ensayos in vivo.To avoid resorting to animal or human experimentation (what is usually called in vivo tests), a synthetic model (called phantom or phantom in Spanish) has been developed that is based on mixtures of different components whose concentrations are adjusted to simulate different tissues humans and organs, and that in part avoids having to resort to those of in vivo trials.
El phantom consiste en una mezcla llquida, que puede estar contenida en el recipiente con las forma y dimensiones que interese, por ejemplo las del organo que imita, o bien puede estar contenida un gel conformable con la forma y dimensiones de interes, capaz de albergar llquidos o mezclas de los mismos en el retlculo polimerico.The phantom consists of a liquid mixture, which can be contained in the container with the shape and dimensions of interest, for example those of the organ that mimics, or it can be contained a conformable gel with the shape and dimensions of interest, capable of housing liquids or mixtures thereof in the polymeric crosslink.
55
1010
15fifteen
20twenty
2525
3030
El documento JP2012110563A describe un phantom para evaluacion de la influencia de la descarga de ondas electromagneticas en un dispositivo medico implantado. El llquido empleado tiene una constante dielectrica similar a la del cuerpo humano y se utiliza para rellenar el phantom hasta una posicion mas elevada que el dispositivo medico.JP2012110563A describes a phantom for evaluation of the influence of electromagnetic wave discharge on an implanted medical device. The liquid used has a dielectric constant similar to that of the human body and is used to fill the phantom to a position higher than the medical device.
El documento JP2006251012A se refiere a un phantom equivalente a un cuerpo vivo, utilizado para investigar la influencia de las ondas electromagneticas de dispositivos electronicos domesticos, como moviles, television, etc., sobre el cuerpo humano. El phantom comprende un peso especlfico de electrolitos y pollmeros absorbedores de agua. Se menciona como ventaja la estabilidad del phantom en rangos de frecuencia de onda amplios.JP2006251012A refers to a phantom equivalent to a living body, used to investigate the influence of electromagnetic waves of domestic electronic devices, such as cell phones, television, etc., on the human body. The phantom comprises a specific weight of electrolytes and water absorbing polymers. The advantage of phantom stability in wide wave frequency ranges is mentioned.
El documento KR20000015490A divulga un phantom humano y una celula de phantom humano de cerebro, craneo, y tejido muscular, para evaluar el efecto electromagnetico.Document KR20000015490A discloses a human phantom and a human phantom cell of the brain, skull, and muscle tissue, to assess the electromagnetic effect.
El documento JPH0546074A describe un llquido biologico para la simulacion electrica del cuerpo que comprende una solucion electrolltica y un compuesto organico polar cerrados hermeticamente en un recipiente con transmitancia electromagnetica especlfica (al menos 0,9). El compuesto organico comprende preferiblemente un alcohol monovalente o polihldrico. El llquido permite mantener la constante dielectrica a traves de un intervalo amplio, simulando de forma precisa las caracterlsticas del cuerpo humano.JPH0546074A describes a biological liquid for the electrical simulation of the body comprising an electrolytic solution and a polar organic compound sealed in a container with specific electromagnetic transmittance (at least 0.9). The organic compound preferably comprises a monovalent or polyhydric alcohol. The liquid allows the dielectric constant to be maintained over a wide range, accurately simulating the characteristics of the human body.
Aunque se han desarrollado phantoms para organos como musculo, cerebro, piel o tejido adiposo, no se han conseguido para hlgado, corazon pancreas, colon o cartllago. Ademas, teniendo en cuenta la amplitud de frecuencias en la radiacion electromagnetica de los distintos dispositivos que nos rodean, es necesario disponer de phantoms adecuados para determinar las repercusiones de ciertos rangos de frecuencias en tejidos biologicos.Although phantoms have been developed for organs such as muscle, brain, skin or adipose tissue, they have not been achieved for liver, heart, pancreas, colon or cartilage. In addition, taking into account the amplitude of frequencies in the electromagnetic radiation of the different devices that surround us, it is necessary to have adequate phantoms to determine the repercussions of certain frequency ranges on biological tissues.
55
1010
15fifteen
20twenty
2525
3030
DESCRIPCION DE LA INVENCIONDESCRIPTION OF THE INVENTION
Los inventores han desarrollado un modelo sintetico de tejidos biologicos u organos basado en una disolucion acuosa de NaCl, acetonitrilo y un disolvente cuyas concentraciones se ajustan para simular distintos tejidos humanos y organos, en lo que se refiere a sus propiedades electromagneticas, permitividad relativa y conductividad dielectrica y conductividad. Este modelo ofrece varias ventajas: evitarla en parte tener que recurrir a la experimentation animal o humana para testear dispositivos inalambricos que se prevea emplear como sensores o sistemas de monitorizacion implantables, se controlarla mejor los experimentos y se evitarla la dependencia de la senal con el individuo bajo estudio.The inventors have developed a synthetic model of biological or organ tissues based on an aqueous solution of NaCl, acetonitrile and a solvent whose concentrations are adjusted to simulate different human and organ tissues, in terms of their electromagnetic properties, relative permittivity and conductivity Dielectric and conductivity. This model offers several advantages: to avoid it in part having to resort to animal or human experimentation to test wireless devices that are expected to be used as implantable sensors or monitoring systems, experiments will be better controlled and the dependence of the signal with the individual be avoided. under study.
Este modelo serla de aplicacion en la evaluation ex vivo (sin hacer uso de modelos animales o humanos) de la propagation de ondas electromagneticas de dispositivos o sistemas desarrollados o en desarrollo, tanto para la comunicacion hacia el exterior del cuerpo desde el interior, como de uso externo, en la banda de frecuencias UWB (ultrawide band) que comprende de 0,5 a 18 GHz.This model would be of application in the ex vivo evaluation (without using animal or human models) of the propagation of electromagnetic waves of developed or developing devices or systems, both for the communication towards the outside of the body from the inside, and from external use, in the UWB (ultrawide band) frequency band comprising 0.5 to 18 GHz.
En un primer aspecto, la presente invention se refiere a un modelo sintetico de tejidos biologicos formado por una disolucion que comprende:In a first aspect, the present invention relates to a synthetic model of biological tissues formed by a solution comprising:
- una sal que se selecciona de entre cloruro sodico, cloruro potasico o bromuro sodico en una proportion del 0 al 5% en peso respecto al total,- a salt selected from sodium chloride, potassium chloride or sodium bromide in a proportion of 0 to 5% by weight with respect to the total,
- acetonitrilo en una proporcion de 10 a 70% en peso respecto al total,- acetonitrile in a proportion of 10 to 70% by weight with respect to the total,
- al menos un disolvente polar en una proporcion de entre 30 a 90%.- at least one polar solvent in a proportion between 30 to 90%.
Las proporciones de cada uno de los componentes se calculan y se anaden de forma que la suma de estos alcance el 100%.The proportions of each of the components are calculated and added so that the sum of these reaches 100%.
En el modelo sintetico de la presente invencion puede usarse cualquier sal que se disocie en iones al disolverse en un disolvente polar, aunque preferiblemente dicha sal es cloruro sodico.In the synthetic model of the present invention any salt that dissociates into ions can be used when dissolved in a polar solvent, although preferably said salt is sodium chloride.
En una realization preferida, el modelo sintetico de la invencion esta formado por una mezcla llquida que comprende:In a preferred embodiment, the synthetic model of the invention is formed by a liquid mixture comprising:
55
1010
15fifteen
20twenty
2525
3030
- cloruro sodico, cloruro potasico o bromuro sodico, en una proportion del 0 al 5% en peso respecto al total,- sodium chloride, potassium chloride or sodium bromide, in a proportion of 0 to 5% by weight with respect to the total,
- acetonitrilo en una proportion de 10 a 60% en peso respecto al total,- acetonitrile in a proportion of 10 to 60% by weight with respect to the total,
- al menos un disolvente polar, en una proportion de entre 40 a 90%.- at least one polar solvent, in a proportion of between 40 to 90%.
En una realization preferida, las mencionadas disoluciones que forman el modelo pueden estar contenidas en un gel polimerico de origen natural o sintetico. Los pollmeros empleados pueden ser de la familia de los acrilatos, acrilamidas, hidroxiacrilatos, alginato, quitosano, acido hialuronico u otros no degradables para evitar su deterioro con el tiempo. Estos materiales se obtienen por polimerizacion radicalaria convencional, a partir del monomero o monomeros correspondientes al pollmero en cuestion, en presencia de un reactivo iniciador de dicha reaction de polimerizacion (peroxido de benzoilo, o benzolna, por ejemplo) y un reticulador (etilenglicol dimetacrilato, por ejemplo), en el molde adecuado para el tejido u organo a simular. Tambien se podrla emplear otros geles pocos reticulados con alta afinidad por el agua, usados convencionalmente como phantoms, como la gelatina o agar, para embeberlos de la mezcla llquida.In a preferred embodiment, said solutions that form the model may be contained in a polymeric gel of natural or synthetic origin. The polymers used can be of the acrylate, acrylamide, hydroxyacrylate, alginate, chitosan, hyaluronic acid or other non-degradable family to avoid deterioration over time. These materials are obtained by conventional radical polymerization, from the monomer or monomers corresponding to the polymer in question, in the presence of an initiating reagent of said polymerization reaction (benzoyl peroxide, or benzolna, for example) and a crosslinker (ethylene glycol dimethacrylate, for example), in the mold suitable for the tissue or organ to simulate. Other few crosslinked gels with high affinity for water, conventionally used as phantoms, such as gelatin or agar, could also be used to soak them in the liquid mixture.
En otra realization preferida, el disolvente polar se selecciona de entre agua, etanol o acetona.In another preferred embodiment, the polar solvent is selected from water, ethanol or acetone.
En otra realization preferida, el modelo comprende un agente biocida que se incorpora a la mezcla de acetonitrilo o al gel polimerico en el que se embebe dicha mezcla, con el fin de prolongar la vida del modelo evitando la proliferation bacteriana. Estos biocidas pueden ser de origen biologico o qulmico. En una realization mas preferida, el agente biocida es la azida de sodio.In another preferred embodiment, the model comprises a biocidal agent that is incorporated into the mixture of acetonitrile or the polymer gel in which said mixture is embedded, in order to prolong the life of the model avoiding bacterial proliferation. These biocides can be of biological or chemical origin. In a more preferred embodiment, the biocidal agent is sodium azide.
Otro aspecto de la invention se refiere al uso del modelo sintetico segun se ha descrito anteriormente para la simulation del comportamiento de tejidos biologicos en la banda de frecuencias de 0,5 a 18 GHz.Another aspect of the invention relates to the use of the synthetic model as described above for the simulation of the behavior of biological tissues in the frequency band of 0.5 to 18 GHz.
El tratamiento matematico realizado a los datos obtenidos con la sonda coaxial con una baterla exhaustiva de disoluciones en las que se ha variado sistematicamente la concentration de cada uno de sus componentes por separado, permite obtener laThe mathematical treatment carried out on the data obtained with the coaxial probe with an exhaustive battery of solutions in which the concentration of each of its components has been systematically varied, allows obtaining the
55
1010
15fifteen
20twenty
2525
3030
formulacion optima para preparar phantoms ‘a la carta’, con la composition qulmica optima para simular el tejido u organo que sea de interes: musculo, hlgado, u otros.Optimal formulation to prepare phantoms ‘à la carte’, with the optimal chemical composition to simulate the tissue or organ of interest: muscle, liver, or others.
La hipotesis de que con estos sistemas se puede obtener analogos de tejidos u organos humanos desde el punto de vista electromagnetico se fundamenta, por un lado, (a) en los resultados obtenidos empleando una sonda coaxial de comunicaciones, que atestiguan que el espectro de permitividad relativa real e imaginaria de las mezclas llquidas preparadas se ajusta al descrito en la literatura para diversos tejidos humanos (musculo, corazon, pancreas, colon, hlgado, cartllago) en el rango de frecuencias entre 0,5 y 18 GHz, y por otro lado que (b) es posible obtener los geles con la forma y dimensiones de interes mediante su polimerizacion en el molde apropiado, y (c) es posible incorporar las mezclas llquidas a estas redes polimericas capaces de hinchar en presencia de ellas.The hypothesis that with these systems analogs of human tissues or organs can be obtained from the electromagnetic point of view is based, on the one hand, (a) on the results obtained using a coaxial communications probe, attesting that the permittivity spectrum Real and imaginary relative of the prepared liquid mixtures conforms to that described in the literature for various human tissues (muscle, heart, pancreas, colon, liver, cartilage) in the frequency range between 0.5 and 18 GHz, and on the other hand that (b) it is possible to obtain gels with the shape and dimensions of interest by polymerization in the appropriate mold, and (c) it is possible to incorporate liquid mixtures into these polymer networks capable of swelling in the presence of them.
Otro aspecto de la invention se refiere al procedimiento de obtencion del modelo sintetico descrito anteriormente que comprende las siguientes etapas:Another aspect of the invention relates to the method of obtaining the synthetic model described above comprising the following steps:
a) preparation de la mezcla llquida por adicion de los componentes segun se han descrito anteriormente ya) preparation of the liquid mixture by adding the components as described above and
b) mezclado y agitation de la disolucion preparada en (a), en frasco cerrado.b) mixing and stirring the solution prepared in (a), in a closed bottle.
En una realization preferida, este procedimiento comprende la adicion de un biocida a la mezcla llquida en el momento de su preparacion.In a preferred embodiment, this process comprises adding a biocide to the liquid mixture at the time of its preparation.
Las disoluciones (mezclas llquidas) se preparan a partir de las concentraciones establecidas en la formulacion, por pesada. Es decir, con la masa de disolucion que se pretende preparar y las concentraciones masicas de cada componente, se calcula en primer lugar la masa de cada componente a emplear. Luego se pesa cada cantidad en una balanza de precision y se va incorporando a un frasco de vidrio que luego se cierra y se mantiene en agitacion, empleando un agitador magnetico, durante una hora para asegurar la correcta mezcla de todos los componentes.The solutions (liquid mixtures) are prepared from the concentrations established in the formulation, by weighing. That is, with the mass of solution to be prepared and the mass concentrations of each component, the mass of each component to be used is calculated first. Each quantity is then weighed on a precision balance and incorporated into a glass jar that is then closed and kept under stirring, using a magnetic stirrer, for one hour to ensure the correct mixing of all components.
En una realizacion preferida, cuando el modelo comprende el gel polimerico en el que luego se incorpora la solution que contiene acetonitrilo, el procedimiento de obtencion del modelo sintetico comprende las siguientes etapas:In a preferred embodiment, when the model comprises the polymer gel in which the solution containing acetonitrile is then incorporated, the method of obtaining the synthetic model comprises the following steps:
55
1010
15fifteen
20twenty
2525
3030
a) preparation de una mezcla reactiva que comprende al menos un monomero formador del polimero final, un iniciador y un agente entrecruzante, y posterior agitation de esta mezcla;a) preparation of a reactive mixture comprising at least one final polymer forming monomer, an initiator and a cross-linking agent, and subsequent agitation of this mixture;
b) polimerizacion de la mezcla reactiva en un molde;b) polymerization of the reaction mixture in a mold;
c) preparation de la mezcla liquida por adicion de los componentes segun se han descrito anteriormente, y posterior mezclado y agitation de dicha mezcla, ec) preparation of the liquid mixture by adding the components as described above, and subsequent mixing and stirring of said mixture, and
d) inmersion del producto obtenido en (b) una vez desmoldado en la mezcla liquida obtenida en (c) para su hinchado hasta equilibrio (cuando ya no es capaz de absorber mas liquido).d) immersion of the product obtained in (b) once demoulded in the liquid mixture obtained in (c) for swelling until equilibrium (when it is no longer able to absorb more liquid).
En el caso de los geles, en primer lugar se preparan las redes polimericas. Esto se hace empleando el monomero del polimero en cuestion, un iniciador de la reaction de polimerizacion y un agente entrecruzante (para evitar la posterior disolucion del polimero). Se mezclan en las proporciones establecidas, y tras agitar una hora se dispone la mezcla en un molde con la forma del organo o tejido que nos interese recrear. Se lleva a cabo la reaction de polimerizacion y luego se eliminan las trazas de monomero residual por lavado en etanol o etanol/agua hirviendo en varios pasos. Finalmente se seca el polimero empleando un desecador de vatio para garantizar la elimination del disolvente de lavado. A continuation, para obtener el phantom, se sumergiria el xerogel para su hinchado hasta equilibrio en la mezcla liquida con la formulation establecida, hasta llegar al equilibrio de hinchado, es decir, hasta que pase suficiente tiempo como para que no se absorba mas liquido.In the case of gels, polymer networks are prepared first. This is done using the polymer monomer in question, an initiator of the polymerization reaction and a crosslinking agent (to avoid the subsequent dissolution of the polymer). They are mixed in the established proportions, and after stirring for an hour the mixture is arranged in a mold with the shape of the organ or tissue that we are interested in recreating. The polymerization reaction is carried out and then traces of residual monomer are removed by washing in ethanol or ethanol / boiling water in several steps. Finally, the polymer is dried using a watt desiccator to guarantee the elimination of the washing solvent. Then, to obtain the phantom, the xerogel would be submerged for swelling until equilibrium in the liquid mixture with the established formulation, until reaching the swelling equilibrium, that is, until sufficient time passes so that no more liquid is absorbed.
A lo largo de la description y las reivindicaciones la palabra "comprende" y sus variantes no pretenden excluir otras caracteristicas tecnicas, aditivos, componentes o pasos. Para los expertos en la materia, otros objetos, ventajas y caracteristicas de la invention se desprenderan en parte de la description y en parte de la practica de la invention. Los siguientes ejemplos y figuras se proporcionan a modo de ilustracion, y no se pretende que sean limitativos de la presente invention.Throughout the description and claims the word "comprises" and its variants are not intended to exclude other technical characteristics, additives, components or steps. For those skilled in the art, other objects, advantages and characteristics of the invention will emerge partly from the description and partly from the practice of the invention. The following examples and figures are provided by way of illustration, and are not intended to be limiting of the present invention.
55
1010
15fifteen
20twenty
2525
3030
BREVE DESCRIPCION DE LAS FIGURASBRIEF DESCRIPTION OF THE FIGURES
FIG. 1. Muestra la permitividad relativa de 0,5 a 18 GHz del phantom del musculo comparado con el modelo de Gabriel y con una disolucion 1M de sacarosa. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 1. It shows the relative permittivity of 0.5 to 18 GHz of the muscle phantom compared to Gabriel's model and with a 1M solution of sucrose. Real part: dielectric constant (left), imaginary part: loss factor (right).
FIG. 2. Muestra la permitividad relativa de 0,5 a 18 GHz del phantom del corazon comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte maginaria: factor de perdidas (derecha).FIG. 2. It shows the relative permittivity of 0.5 to 18 GHz of the heart phantom compared to Gabriel's model. Real part: dielectric constant (left), maginary part: loss factor (right).
FIG. 3. Muestra la permitividad relativa de 0,5 a 18 GHz del phantom del pancreas comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 3. It shows the relative permittivity of 0.5 to 18 GHz of the pancreas phantom compared to Gabriel's model. Real part: dielectric constant (left), imaginary part: loss factor (right).
FIG. 4. Muestra la permitividad relativa en la banda UWB del phantom del colon comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 4. Shows the relative permittivity in the UWB band of the colon phantom compared to Gabriel's model. Real part: dielectric constant (left), imaginary part: loss factor (right).
FIG. 5: Muestra la permitividad relativa de 0,5 a 18 GHz del phantom del hlgado comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 5: Shows the relative permittivity of 0.5 to 18 GHz of the liver phantom compared to Gabriel's model. Real part: dielectric constant (left), imaginary part: loss factor (right).
FIG. 6: Muestra la permitividad relativa de 0,5 a 18 GHz del phantom del cartllago comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 6: It shows the relative permittivity of 0.5 to 18 GHz of the carthage phantom compared to Gabriel's model. Real part: dielectric constant (left), imaginary part: loss factor (right).
FIG. 7: Muestra la permitividad relativa en la banda UWB del phantom gel del hlgado comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 7: Shows the relative permittivity in the UWB band of the liver gel phantom compared to Gabriel's model. Real part: dielectric constant (left), imaginary part: loss factor (right).
FIG. 8: Muestra la permitividad relativa en la banda UWB del phantom gel del corazon comparado con el modelo de Gabriel. Parte real: constante dielectrica (izquierda), parte imaginaria: factor de perdidas (derecha).FIG. 8: Shows the relative permittivity in the UWB band of the heart gel phantom compared to Gabriel's model. Real part: dielectric constant (left), imaginary part: loss factor (right).
55
1010
15fifteen
20twenty
2525
3030
EJEMPLOSEXAMPLES
A continuation se ilustrara la invention mediante unos ensayos realizados por los inventores, que pone de manifiesto la efectividad del producto de la invention.The invention will be illustrated below by tests carried out by the inventors, which shows the effectiveness of the product of the invention.
En primer lugar se muestran como ejemplo algunos de los phantoms llquidos sintetizados:First, some of the synthesized liquid phantoms are shown as an example:
EJEMPLO 1EXAMPLE 1
En la Figura 1, se muestran las graficas correspondientes al phantom del musculo, que es el tejido considerado como mas importante desde el punto de vista de conseguir imitar, ya que representa una parte muy voluminosa del cuerpo y es donde probablemente se implantaran mas sensores en un futuro. La composition de este phantom es 54,98%wt acetonitrilo (Scharlab), 1,07%wt NaCl (99% pureza; Panreac) en agua desionizada; la mezcla se preparo como se ha descrito mas arriba. El espectro se obtuvo empleando una sonda coaxial terminada en abierto. Se ha representado junto al modelo de Gabriel [C. Gabriel, “Compilation of the Dielectric Properties of Body Tissues at RF and Microwave Frequencies” Environ. Heal., no. June, p. 21, 1996. S. Gabriel, R. W. Lau, and C. Gabriel, “The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz" Phys. Med. Biol., vol. 41, pp. 2251-2269, 1996.], en este caso en el rango entre 0,5 y 18 GHz, para apreciar el nivel de aproximacion y junto a una disolucion 1M de sacarosa, que es la solution adoptada hasta el momento en la mayorla de publicaciones para imitar el musculo. La aproximacion que se consigue con el phantom propuesto es casi perfecta, mucho mejor que la obtenida con una disolucion de sacarosa.In Figure 1, the graphs corresponding to the phantom of the muscle are shown, which is the tissue considered as most important from the point of view of imitating, since it represents a very voluminous part of the body and is where more sensors will probably be implanted in a future. The composition of this phantom is 54.98% wt acetonitrile (Scharlab), 1.07% wt NaCl (99% purity; Panreac) in deionized water; The mixture was prepared as described above. The spectrum was obtained using an open ended coaxial probe. He has been represented alongside Gabriel's model [C. Gabriel, “Compilation of the Dielectric Properties of Body Tissues at RF and Microwave Frequencies” Environ. Heal., No. June, p. 21, 1996. S. Gabriel, R. W. Lau, and C. Gabriel, “The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz "Phys. Med. Biol., Vol. 41, pp. 2251-2269, 1996.], in this case in the range between 0.5 and 18 GHz, to appreciate the level of approximation and together with a 1M solution of sucrose, which is the solution adopted so far in most publications to mimic the muscle.The approximation achieved with the proposed phantom is almost perfect, much better than that obtained with a solution of sucrose.
EJEMPLO 2EXAMPLE 2
El phantom de corazon, otro tejido con alto contenido en agua y propiedades similares a las del musculo, se preparo con 49,94%wt acetonitrilo, 1,58%wt NaCl en agua desionizada. En la Figura 2 se muestran las curvas de la constante dielectrica y del factor de perdidas del phantom, de nuevo comparado con los espectros del musculo cardiaco segun Gabriel, y en el rango de frecuencias entre 0,5 y 18 GHz.Heart phantom, another tissue with a high water content and properties similar to those of muscle, was prepared with 49.94% wt acetonitrile, 1.58% wt NaCl in deionized water. Figure 2 shows the curves of the dielectric constant and the phantom loss factor, again compared to the heart muscle spectra according to Gabriel, and in the frequency range between 0.5 and 18 GHz.
55
1010
15fifteen
20twenty
2525
3030
En este caso, se obtuvo una pendiente mas pronunciada que el musculo en la parte real, pero la maxima desviacion producida es de una unidad en la parte real en las frecuencias inicial y final medidas, siendo el factor de perdidas identico.In this case, a steeper slope than the muscle in the real part was obtained, but the maximum deviation produced is one unit in the real part at the initial and final measured frequencies, being the identical loss factor.
EJEMPLO3EXAMPLE 3
El phantom de pancreas se preparo como una disolucion acuosa de 44,49%wt acetonitrilo y 1,09%wt NaCl. Los espectros del phantom y del tejido segun Gabriel se muestran en la Figura 3, de nuevo entre 0,5 y 18 GHz.The pancreas phantom was prepared as an aqueous solution of 44.49% wt acetonitrile and 1.09% wt NaCl. Phantom and tissue spectra according to Gabriel are shown in Figure 3, again between 0.5 and 18 GHz.
La aproximacion del modelo sintetico al comportamiento real de los tejidos es elevada, ya que la parte real sigue la misma tendencia en la calda y solo hay una desviacion de alrededor de una unidad, que esta dentro del rango de la variacion producida por cambios de temperatura, asl que no es significativa. El factor de perdidas tiene una curva practicamente identica al modelo de Gabriel, por lo que la aproximacion en esta parte es incluso mejor a la de la real.The approximation of the synthetic model to the real behavior of the tissues is high, since the real part follows the same trend in the broth and there is only a deviation of about one unit, which is within the range of the variation produced by temperature changes , so it is not significant. The loss factor has a curve practically identical to Gabriel's model, so the approximation in this part is even better than the real one.
EJEMPLO 4EXAMPLE 4
El phantom de colon se obtuvo, por un lado con una mezcla de 52,29%wt acetonitrilo y 1,42%wt NaCl en agua desionizada, o aun mejor, con una mezcla 48,5%wt acetonitrilo, 1,165%wt NaCl y 2,5%wt etanol (Scharlab) en agua desionizada. Se muestran en la Figura 4 ambos espectros junto con el de colon segun Gabriel.The colon phantom was obtained, on the one hand, with a mixture of 52.29% wt acetonitrile and 1.42% wt NaCl in deionized water, or even better, with a mixture 48.5% wt acetonitrile, 1,165% wt NaCl and 2.5% wt ethanol (Scharlab) in deionized water. Both spectra are shown in Figure 4 along with that of the colon according to Gabriel.
Con el etanol se consigue asemejar mas la curva del phantom a la del tejido real sin afectar de manera notable a los valores de la constante dielectrica ni al factor de perdidas. A pesar de ser una pequena cantidad de etanol, la calda que produce en la curva de la parte real es significativa, debido a que su frecuencia de relajacion es mucho menor tanto a la del agua como a la del acetonitrilo. Anadiendo cantidades mas importantes de etanol se podrlan conseguir valores que no son posibles limitando las disoluciones a agua, acetonitrilo y sal.With ethanol, the phantom curve is more similar to that of the real tissue without significantly affecting the dielectric constant values or the loss factor. In spite of being a small amount of ethanol, the broth that it produces in the curve of the real part is significant, because its relaxation frequency is much lower both to that of water and to that of acetonitrile. By adding more significant amounts of ethanol, values that are not possible can be achieved by limiting the solutions to water, acetonitrile and salt.
El acetonitrilo y el etanol reducen la constante dielectrica del agua a todas las frecuencias, aunque el etanol lo hace de un modo mayor. Al mismo tiempo que reducen el valor de la parte real, el acetonitrilo reduce la pendiente y el etanol la aumenta, asl que en este sentido tienen comportamientos opuestos. El NaCl baja lasAcetonitrile and ethanol reduce the dielectric constant of water at all frequencies, although ethanol does so in a greater way. While reducing the value of the real part, acetonitrile reduces the slope and ethanol increases it, so that in this sense they have opposite behaviors. NaCl lowers
55
1010
15fifteen
20twenty
2525
3030
curvas sin modificar la pendiente, aunque su influencia mas bien se centra en la parte imaginaria. En la parte imaginaria tambien tienen comportamientos diferentes. Mientras que el acetonitrilo baja las perdidas del agua a todas las frecuencias, el etanol las aumenta y su incorporation a altas proporciones puede provocar que el maximo de perdidas se produzca dentro del rango UWB. El NaCl aumenta el factor de perdidas unicamente a las primeras frecuencias estudiadas, convergiendo en un punto a las mas altas, en las que la sal no ejerce ninguna influencia. El unico modo de regular las perdidas a altas frecuencias es, pues, variando la proportion de acetonitrilo.curves without modifying the slope, although its influence is rather centered on the imaginary part. In the imaginary part they also have different behaviors. While acetonitrile lowers water losses at all frequencies, ethanol increases them and their incorporation at high rates can cause maximum losses to occur within the UWB range. NaCl increases the loss factor only at the first frequencies studied, converging at one point to the highest, in which the salt does not exert any influence. The only way to regulate losses at high frequencies is, therefore, by varying the proportion of acetonitrile.
EJEMPLO5EXAMPLE 5
El phantom de hlgado se obtuvo con una mezcla de 51%wt acetonitrilo, 0,95%wt NaCl y 17%wt etanol en agua desionizada. Se muestra en la Figura 5 su espectro junto con el de hlgado segun Gabriel, entre 0,5 y 18 GHz.The liver phantom was obtained with a mixture of 51% wt acetonitrile, 0.95% wt NaCl and 17% wt ethanol in deionized water. Its spectrum is shown in Figure 5 along with that of liver according to Gabriel, between 0.5 and 18 GHz.
En la parte real no se consiguio la misma pendiente que el modelo de Gabriel, aunque con un nivel de acercamiento muy elevado y una desviacion minima a todas las frecuencias La solution hubiese sido anadir mas acetonitrilo, que baja los valores y reduce la pendiente, pero eso habrla bajado el factor de perdidas a altas frecuencias, cosa que no es de interes.In the real part, the same slope as Gabriel's model was not achieved, although with a very high approach level and a minimum deviation at all frequencies The solution would have been to add more acetonitrile, which lowers the values and reduces the slope, but that would have lowered the loss factor at high frequencies, which is not of interest.
EJEMPLO 6EXAMPLE 6
Entre los tejidos con alto contenido en agua que no se podlan modelar usando acetonitrilo, agua y cloruro sodico unicamente, se encontraba tambien el cartllago, por tener unos valores de constante dielectrica mucho menores que el agua y con una fuerte pendiente imposible de reproducir con el uso unicamente de acetonitrilo. En este caso fue necesaria una concentration importante de etanol para conseguir dicha pendiente. El phantom de cartllago se obtuvo con una mezcla de 41%wt acetonitrilo, 1%wt NaCl y 30%wt etanol en agua desionizada. Se muestra en la Figura 6 su espectro junto con el de cartllago segun Gabriel, entre 0,5 y 18 GHz.Among the tissues with high water content that cannot be modeled using acetonitrile, water and sodium chloride only, the cartilage was also found, having dielectric constant values much lower than water and with a steep slope impossible to reproduce with the use of acetonitrile only. In this case, an important concentration of ethanol was necessary to achieve this slope. Carthage phantom was obtained with a mixture of 41% wt acetonitrile, 1% wt NaCl and 30% wt ethanol in deionized water. Its spectrum is shown in Figure 6 along with that of cartilage according to Gabriel, between 0.5 and 18 GHz.
En la parte real de la permitividad se presenta una desviacion del phantom respecto al tejido real en torno a una unidad, pero respetando la calda que se produce con la frecuencia que es igual en ambas curvas. Esto representa aproximadamente unaIn the real part of the permittivity there is a deviation of the phantom with respect to the real tissue around a unit, but respecting the broth that occurs with the frequency that is the same in both curves. This represents approximately one
55
1010
15fifteen
20twenty
2525
3030
desviacion del 2,5% a 3 GHz y del 3,5% a 8,5 GHz. Como en el caso del hlgado, se pierde aproximacion intencionadamente en la parte real para reproducir niveles extraordinarios de imitacion de la parte imaginaria, donde se ajustan notablemente tanto la tendencia de la curva como los valores a todas las frecuencias.deviation of 2.5% at 3 GHz and 3.5% at 8.5 GHz. As in the case of the liver, an approach is intentionally lost in the real part to reproduce extraordinary levels of imitation of the imaginary part, where they are adjusted notably both the trend of the curve and the values at all frequencies.
EJEMPLO7EXAMPLE 7
El hlgado se puede imitar tambien con un phantom solido (o phantom gel), en este ejemplo empleando poliacrilamida (PAM). En primer lugar se preparo PAM entrecruzada un 0,125%wt. Para ello se mezclo en un frasco ISO de vidrio el monomero acrilamida (Scharlau), N,N’-metilenbisacrilamida (NMBA) (Sigma-Aldrich), como agente entrecruzador con el fin de obtener una red polimerica, y persulfato de amonio (PSA) (Avocado) como iniciador de la reaccion de polimerizacion. El PSA se rompe homollticamente en presencia de luz UV y forma radicales libres que atacan el doble enlace entre carbonos de la acrilamida. Esta mezcla se mantuvo en agitacion, sobre un agitador magnetico, en frasco cerrado durante 1 h. La polimerizacion se llevo a cabo en este caso en un molde plano transparente, de vidrio, de 2 mm de espesor interno, con un orificio por donde se introdujo la mezcla reactiva. Se tapo el orificio y la polimerizacion se llevo a cabo en horno ultravioleta durante 24h, seguidas de una post-polimerizacion en horno de conveccion forzada a 90°C durante otras 24 h. A continuation, y tras desmoldear, se lavaron los materiales en etanol hirviendo durante 2 dlas, cambiando el etanol cada 8 h. De esta manera se eliminaron los residuos no polimerizados. Finalmente, se troquelaron con diametro de 12 mm.The liver can also be mimicked with a solid phantom (or phantom gel), in this example using polyacrylamide (PAM). First, 0.125% wt cross-linked PAM was prepared. For this purpose, the acrylamide monomer (Scharlau), N, N'-methylenebisacrylamide (NMBA) (Sigma-Aldrich) was mixed in an ISO glass jar, in order to obtain a polymeric network, and ammonium persulfate (PSA ) (Avocado) as the initiator of the polymerization reaction. PSA breaks homoltically in the presence of UV light and forms free radicals that attack the double bond between acrylamide carbons. This mixture was kept under stirring, on a magnetic stirrer, in a closed bottle for 1 h. The polymerization was carried out in this case in a transparent flat glass mold of 2 mm internal thickness, with a hole through which the reaction mixture was introduced. The hole was plugged and the polymerization was carried out in an ultraviolet oven for 24 hours, followed by a post-polymerization in a forced convection oven at 90 ° C for another 24 hours. Then, and after demolding, the materials were washed in boiling ethanol for 2 days, changing the ethanol every 8 h. In this way the unpolymerized residues were removed. Finally, they were punched with a diameter of 12 mm.
La temperatura de transition vltrea de la PAM es de 165 °C, esto quiere decir que a temperatura ambiente y en estado xerogel se comportara como un vidrio. Por este motivo, y porque el cambio a estado vltreo es muy brusco y probablemente quebrarla el material, los geles PAM no se secaron. Los materiales se hincharon hasta equilibrio en una disolucion de 35%wt acetonitrilo y 0,75%wt NaCl, que se renovo varias veces para asegurar la elimination del etanol. La Figura 7 muestra la constante dielectrica y el factor de perdidas. Tanto la parte real como la imaginaria del phantom siguen la tendencia de las curvas de Gabriel, habiendo una desviacion minima en ambas partes.The glass transition temperature of the PAM is 165 ° C, this means that at room temperature and in the xerogel state it will behave like glass. For this reason, and because the change to the vitreous state is very abrupt and the material will probably break it, the PAM gels did not dry out. The materials were swollen to equilibrium in a solution of 35% wt acetonitrile and 0.75% wt NaCl, which was renewed several times to ensure the elimination of ethanol. Figure 7 shows the dielectric constant and the loss factor. Both the real and the imaginary part of the phantom follow the trend of Gabriel's curves, with a minimal deviation in both parts.
EJEMPLO8EXAMPLE 8
En la Figura 8 se representan los graficos del phantom solido correspondiente al corazon, preparado de nuevo a partir de PAM entrecruzado un 0,125%wt e hinchado en una disolucion acuosa con un 19,5%wt de acetonitrilo y 1,25%wt de NaCl. Los 5 valores son muy parecidos a los de Gabriel en ambas partes de la permitividad relativa, siendo unicamente relevante la desviacion que se produce en la constante dielectrica a altas frecuencias, aunque en ningun caso es superior a la unidad.Figure 8 shows the graphs of the solid phantom corresponding to the heart, prepared again from PAM crosslinked 0.125% wt and swollen in an aqueous solution with 19.5% wt of acetonitrile and 1.25% wt of NaCl . The 5 values are very similar to those of Gabriel in both parts of the relative permittivity, the deviation that occurs in the dielectric constant at high frequencies being only relevant, although in no case is it greater than unity.
1010
Claims (13)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531877A ES2575731B1 (en) | 2015-12-22 | 2015-12-22 | Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves |
| PCT/ES2016/070912 WO2017109252A1 (en) | 2015-12-22 | 2016-12-20 | Synthetic model of biological tissues for evaluating the wireless transmission of electromagnetic waves |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531877A ES2575731B1 (en) | 2015-12-22 | 2015-12-22 | Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2575731A1 ES2575731A1 (en) | 2016-06-30 |
| ES2575731B1 true ES2575731B1 (en) | 2017-05-04 |
Family
ID=56190131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201531877A Active ES2575731B1 (en) | 2015-12-22 | 2015-12-22 | Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves |
Country Status (2)
| Country | Link |
|---|---|
| ES (1) | ES2575731B1 (en) |
| WO (1) | WO2017109252A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0546074A (en) * | 1991-08-12 | 1993-02-26 | Nippon Telegr & Teleph Corp <Ntt> | Living body phantom |
| JP2006251012A (en) * | 2005-03-08 | 2006-09-21 | Yokohama Rubber Co Ltd:The | Biological equivalent phantom and manufacturing method of the same |
| TWI338584B (en) * | 2007-10-16 | 2011-03-11 | Ind Tech Res Inst | Tissue mimicking phantom |
-
2015
- 2015-12-22 ES ES201531877A patent/ES2575731B1/en active Active
-
2016
- 2016-12-20 WO PCT/ES2016/070912 patent/WO2017109252A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017109252A1 (en) | 2017-06-29 |
| ES2575731A1 (en) | 2016-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fang et al. | Salt sensitive purely zwitterionic physical hydrogel for prevention of postoperative tissue adhesion | |
| Pourjavadi et al. | Injectable chitosan/κ-carrageenan hydrogel designed with au nanoparticles: A conductive scaffold for tissue engineering demands | |
| US9330578B2 (en) | Intelligent tissue mimicking ultrasonic phantom and method of preparing the same | |
| US20130122477A1 (en) | Materials Formulations for Human Tissue Simulation | |
| Bootsma et al. | 3D printing of an interpenetrating network hydrogel material with tunable viscoelastic properties | |
| ES2181608T3 (en) | PROCEDURE FOR THE PRODUCTION OF MULTIPLE SHAPED DERIVAODS OF HIALURONIC ACID. | |
| JP3359036B2 (en) | Biocompatible hydrogel | |
| US8025696B2 (en) | Artificial meniscus and process of making thereof | |
| Rosiak et al. | Nano-, micro-and macroscopic hydrogels synthesized by radiation technique | |
| Kanyuck et al. | Swelling of high acyl gellan gum hydrogel: Characterization of network strengthening and slower release | |
| JPS62249644A (en) | Dummy living body structure | |
| ES2237588T3 (en) | POLYACRILAMIDE HYDROGEL AND ITS USE AS ENDOPROTESIS. | |
| ES2575731B1 (en) | Synthetic model of biological tissues for the evaluation of wireless transmission of electromagnetic waves | |
| US20100303911A1 (en) | Hydrogel systems | |
| Permana et al. | Hermetic implantable antenna inside vitreous humor simulating fluid | |
| US4622367A (en) | X-ray contrast spherical hydrogel particles based on polymer and copolymers of acrylates and methacrylates and the method for preparation thereof | |
| Pourjavadi et al. | Alginate‐based biodegradable superabsorbents as candidates for diclofenac sodium delivery systems | |
| US9179997B2 (en) | Thermochromic polyvinyl alcohol based hydrogel artery | |
| CN102831810A (en) | Human-eye simulation calibrating model | |
| Damani et al. | Stimuli-Responsive Conductive Polymers for Bioelectronics | |
| CN108806447A (en) | Arthroscopic diagnosis training pattern and preparation method thereof in a kind of cerebral hemorrhage | |
| PT2178931E (en) | High ion and metabolite flux lenses and materials | |
| Yu et al. | Versatile and tunable performance of PVA/PAM tridimensional hydrogel models for tissues and organs: augmenting realism in advanced surgical training | |
| Doğancı et al. | Preparation of a human skin-mimicking gels for in vitro measurements of the dual-band medical implant antenna | |
| Ibrahim et al. | Short review on the used recipes to simulate the bio-tissue at microwave frequencies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2575731 Country of ref document: ES Kind code of ref document: B1 Effective date: 20170504 |